NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,996,162 | -5.3% | 45,111 | +4.2% | 0.02% | 0.0% |
Q2 2023 | $2,107,610 | -4.4% | 43,313 | +9.1% | 0.02% | -10.5% |
Q1 2023 | $2,203,589 | -0.7% | 39,690 | -28.1% | 0.02% | 0.0% |
Q4 2022 | $2,218,910 | +40.3% | 55,238 | +53.1% | 0.02% | +35.7% |
Q3 2022 | $1,582,000 | -0.7% | 36,089 | -19.7% | 0.01% | +7.7% |
Q2 2022 | $1,593,000 | -46.7% | 44,965 | +40.5% | 0.01% | -18.8% |
Q4 2021 | $2,988,000 | +0.8% | 31,999 | +20.3% | 0.02% | -11.1% |
Q3 2021 | $2,964,000 | -9.9% | 26,599 | -8.2% | 0.02% | -5.3% |
Q2 2021 | $3,289,000 | +16.3% | 28,973 | +4.0% | 0.02% | 0.0% |
Q1 2021 | $2,829,000 | +1.5% | 27,860 | -0.5% | 0.02% | +11.8% |
Q4 2020 | $2,788,000 | – | 28,010 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |